GALVEZ, K. Efficacy of Generic Bortezomib Used as a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma. Innovative Journal of Medical and Health Sciences, [S. l.], v. 9, n. 1, p. 247–251, 2019. DOI: 10.15520/ijmhs.v9i1.2431. Disponível em: http://innovativejournal.in/index.php/ijmhs/article/view/2431. Acesso em: 4 may. 2024.